A detailed history of Cinctive Capital Management LP transactions in Argenx Se stock. As of the latest transaction made, Cinctive Capital Management LP holds 3,418 shares of ARGX stock, worth $1.93 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,418
Previous 6,881 50.33%
Holding current value
$1.93 Million
Previous $2.96 Million 37.38%
% of portfolio
0.11%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $1.5 Million - $1.91 Million
-3,463 Reduced 50.33%
3,418 $1.85 Million
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $1.57 Million - $1.99 Million
4,399 Added 177.24%
6,881 $2.96 Million
Q1 2024

May 15, 2024

BUY
$356.95 - $413.29 $459,394 - $531,904
1,287 Added 107.7%
2,482 $977,000
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $404,997 - $604,681
1,195 New
1,195 $454,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.